Bio-Techne (TECH) Revenue — Quarter Ended Jun 30, 2024
Revenue for the quarter ended June 30, 2024 increased compared to both the prior quarter and the same quarter last year. The company reported a sequential rise and a year-over-year gain.
Key takeaway
Quarter ended Jun 30, 2024 · FY2024 Q4
Revenue for the quarter ended June 30, 2024 increased compared to both the prior quarter and the same quarter last year. The company reported a sequential rise and a year-over-year gain.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$306.1M
Revenue reported for this quarter.
Quarter-over-quarter
+0.9%
Change from the immediately preceding quarter.
Year-over-year
+1.6%
Change from the comparable year-ago quarter.
Trailing four quarters
$1.2B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2023 | $276.9M | +2.7% |
| Dec 31, 2023 | $272.6M | +0.4% |
| Mar 31, 2024 | $303.4M | +3.2% |
| Jun 30, 2024 | $306.1M | +1.6% |
Revenue performance
The reported revenue direction was upward, with a modest sequential increase from the immediately preceding quarter and a larger year-over-year gain compared to the same quarter one year earlier.
Quarterly comparison
Compared to the immediately preceding quarter, revenue rose slightly. Versus the same quarter one year earlier, revenue also increased, reflecting sustained growth.
What to watch
Cash and cash equivalents decreased year-over-year, while borrowings under the revolving credit facility increased, warranting attention to liquidity trends.